Literature DB >> 12691130

Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine.

Naohiro Tsuyuguchi1, Ichiro Sunada, Kenji Ohata, Toshihiro Takami, Akimasa Nishio, Mitsuhiro Hara, Joji Kawabe, Terue Okamura, Hironobu Ochi.   

Abstract

Positron emission tomography (PET) imaging is in common use preoperatively to clinically evaluate patients who present with central nervous system mass lesions. The usefulness of PET is also recognized as a method to detect intracranial tumorous lesions. A number of papers reportthat some inflammatory processes also showed the uptake of Fluorine-18-Fluorodeoxyglucose (FDG) and Carbon-11-Methionine (Met) tracers. We performed two PET studies before and after treatment in 4 patients with brain abscess. PET showed the uptake of both tracers to thebrain abscess before treatment. The area showing an increased uptake of Met corresponded closely to the enhanced area on both CT and MR images. FDG-PET visually showed an uptake of FDG in a small area corresponding to an enhanced lesion within the CT and MR images. After treatment the area of lesions became small on enhancement CT or MRI and both PET studies showed reduced lesion and decreased uptake. The mechanism of Met uptake in the inflammatory area may be related to the higher metabolic rate and the active transport of amino acids as well as disruption of the blood brain barrier. Furthermore, it appears that the mechanism of FDG uptake is also related to a higher metabolic rate and, in addition, is related to the increased density of inflammatory cells. PET studies, more directly, reflect the degree of inflammatory response in brain abscess than enhancement CT or MRI. Therefore, PET is useful in detecting the inflammatory lesion and assessing the clinical effects of antibiotics treatment on brain abscesses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691130     DOI: 10.1007/BF02988258

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  14 in total

Review 1.  Molecular imaging of gliomas with PET: opportunities and limitations.

Authors:  Christian la Fougère; Bogdana Suchorska; Peter Bartenstein; Friedrich-Wilhelm Kreth; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2011-07-13       Impact factor: 12.300

2.  Amino acid PET and clinical management of glioma patients.

Authors:  Karl Herholz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-28       Impact factor: 9.236

Review 3.  11C-methionine PET/CT findings in benign brain disease.

Authors:  Reiko Nakajima; Ken Kimura; Koichiro Abe; Shuji Sakai
Journal:  Jpn J Radiol       Date:  2017-04-18       Impact factor: 2.374

4.  Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).

Authors:  Francisco-Javier Peñalver; Juan-Manuel Sancho; Adolfo de la Fuente; María-Teresa Olave; Alejandro Martín; Carlos Panizo; Elena Pérez; Antonio Salar; Alberto Orfao
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

5.  The role of f-fluorodeoxyglucose positron emission tomography in the treatment of brain abscess.

Authors:  Seong-Hyun Park; Sang-Woo Lee; Dong-Hun Kang; Jeong-Hyun Hwang; Joo-Kyung Sung; Sung-Kyoo Hwang
Journal:  J Korean Neurosurg Soc       Date:  2011-05-31

6.  18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET.

Authors:  Tadashi Watabe; Hayato Ikeda; Shushi Nagamori; Pattama Wiriyasermkul; Yoko Tanaka; Sadahiro Naka; Yasukazu Kanai; Kohei Hagiwara; Masanao Aoki; Eku Shimosegawa; Yoshikatsu Kanai; Jun Hatazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-22       Impact factor: 9.236

Review 7.  Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.

Authors:  Csaba Juhász; Shalini Dwivedi; David O Kamson; Sharon K Michelhaugh; Sandeep Mittal
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488

8.  Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.

Authors:  Shuntaro Oka; Hiroyuki Okudaira; Masahiro Ono; David M Schuster; Mark M Goodman; Keiichi Kawai; Yoshifumi Shirakami
Journal:  Mol Imaging Biol       Date:  2014-06       Impact factor: 3.488

9.  The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II.

Authors:  Anja Smits; Brigitta G Baumert
Journal:  Int J Mol Imaging       Date:  2011-04-28

10.  Novel positron emission tomography radiotracers in brain tumor imaging.

Authors:  Maria Mathew D'Souza; Rajnish Sharma; Madhavi Tripathi; Puja Panwar; Abhinav Jaimini; Anupam Mondal
Journal:  Indian J Radiol Imaging       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.